Tarsus Pharmaceuticals Ownership | Who Owns Tarsus Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Tarsus Pharmaceuticals Ownership Summary


Tarsus Pharmaceuticals is owned by 57.97% institutional investors, 3.04% insiders, and 38.99% retail investors. Blackrock is the largest institutional shareholder, holding 9.25% of TARS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.98% of its assets in Tarsus Pharmaceuticals shares.

TARS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTarsus Pharmaceuticals57.97%3.04%38.99%
SectorHealthcare Stocks 231.98%10.74%-142.72%
IndustryBiotech Stocks 381.47%10.55%-292.02%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock3.27M9.25%$88.79M
Blackrock funding, inc. /de3.79M8.90%$310.37M
Rtw investments, lp3.18M7.50%$188.84M
Deep track capital, lp3.00M7.08%$178.29M
Paradigm biocapital advisors lp2.67M6.29%$158.42M
Cowen and company2.20M6.22%$59.72M
Tang capital management2.45M5.79%$145.89M
Vanguard group2.40M5.63%$196.48M
Jennison associates2.23M5.23%$182.60M
Morgan stanley2.04M4.79%$167.10M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Tang capital management2.45M5.62%$145.89M
Deep track capital, lp3.00M4.98%$178.29M
Paradigm biocapital advisors lp2.67M4.51%$158.42M
Bioimpact capital341.50K3.32%$20.30M
Ally bridge group (ny)70.78K2.56%$4.21M
Cutter capital management, lp112.50K2.55%$6.23M
Rtw investments, lp3.18M2.33%$188.84M
Sands capital ventures170.00K2.21%$10.10M
Frazier life sciences management1.17M2.08%$69.39M
Ghost tree capital235.00K2.00%$6.39M

Top Buyers

HolderShares% AssetsChange
Deep track capital, lp3.00M4.98%1.25M
Blackrock3.27M0.00%614.03K
Millennium management644.01K0.02%421.50K
Franklin resources337.02K0.01%314.83K
D. e. shaw365.54K0.01%183.45K

Top Sellers

HolderShares% AssetsChange
Exoduspoint capital management, lp---883.04K
Macquarie group---833.44K
Vivo capital---565.55K
Adage capital partners gp---543.00K
Toronto dominion bank617.58K0.06%-384.38K

New Positions

HolderShares% AssetsChangeValue
Caption management160.00K0.07%160.00K$4.35M
Norges bank117.59K0.00%117.59K$9.63M
Cutter capital management, lp112.50K2.55%112.50K$6.23M
Healthcare of ontario pension plan trust fund100.00K0.01%100.00K$5.94M
Cubist systematic strategies73.95K0.02%73.95K$4.40M

Sold Out

HolderChange
Twin peaks wealth advisors-1.00
Capital performance advisors llp-5.00
Nelson, van denburg & campbell wealth management group-5.00
Stephens consulting-10.00
Riggs asset managment-10.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2025158-29.15%24,700,440-44.97%570.52%84-21.50%52-41.57%
Sep 30, 202521710.15%44,818,3855.19%1051.05%105-17.32%8580.85%
Jun 30, 20252026.32%46,119,7906.86%1080.90%12730.93%49-30.99%
Mar 31, 2025193-3.02%43,559,2058.22%1101.01%100-16.67%7129.09%
Dec 31, 202462-63.10%11,285,757-73.99%290.23%40-58.33%14-68.18%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.27M2.98%-21.49K
Vanguard US Total Market Shares ETF1.14M2.73%-
iShares Russell 2000 ETF943.85K2.22%570.98K
PGIM Jennison Small Company A512.82K1.21%-
Jennison SMid Cap Core Equity512.82K1.21%-120.79K
Macquarie Small Cap Growth C478.19K1.13%-73.10K
Invesco Small Cap Value A457.84K1.09%-51.75K
MEDICAL BioHealth EUR Acc441.35K1.04%-40.42K
Lord Abbett Developing Growth A426.26K1.00%-45.74K
Vanguard Institutional Extnd Mkt Idx Tr422.57K0.99%1.72K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2026Neervannan Seshadri Chief Operating OfficerSell$641.42K
Jan 02, 2026Whitfield Dianne C. Chief Human Resources OfficerSell$457.71K
Jan 02, 2026Whitfield Dianne C. Chief Human Resources OfficerSell$655.53K
Jan 02, 2026Whitfield Dianne C. Chief Human Resources OfficerSell$68.39K
Jan 02, 2026Whitfield Dianne C. Chief Human Resources OfficerSell$74.06K

Insider Transactions Trends


DateBuySell
2026 Q1-5
2025 Q4-9
2025 Q3-3
2025 Q2-3
2025 Q1-19

TARS Ownership FAQ


Who Owns Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals shareholders are primarily institutional investors at 57.97%, followed by 3.04% insiders and 38.99% retail investors. The average institutional ownership in Tarsus Pharmaceuticals's industry, Biotech Stocks , is 381.47%, which Tarsus Pharmaceuticals falls below.

Who owns the most shares of Tarsus Pharmaceuticals?

Tarsus Pharmaceuticals’s largest shareholders are Blackrock (3.27M shares, 9.25%), Blackrock funding, inc. /de (3.79M shares, 8.90%), and Rtw investments, lp (3.18M shares, 7.50%). Together, they hold 25.65% of Tarsus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Tarsus Pharmaceuticals?

Yes, BlackRock owns 9.25% of Tarsus Pharmaceuticals, totaling 3.27M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 88.79M$. In the last quarter, BlackRock increased its holdings by 614.03K shares, a 23.15% change.

Who is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Tang capital management is Tarsus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 5.62% of its assets in 2.45M Tarsus Pharmaceuticals shares, valued at 145.89M$.

Who is the top mutual fund holder of Tarsus Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Tarsus Pharmaceuticals shares, with 2.98% of its total shares outstanding invested in 1.27M Tarsus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools